Company · CIK 0001801170 · SIC 6324 — Hospital & Medical Service Plans · Nasdaq
CLOVER HEALTH INVESTMENTS, CORP. /DE · CLOV
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 SForm 4 → | Sep 18, 4:22 pm EDT | Jamie L. ReynosoCEO, Medicare Advantage | 1,921 | $4.56 | $8,760 | 2,803,446 | −0.07% | 10b5-1 |
| Sep 16, 2026 SForm 4 → | Sep 17, 5:29 pm EDT | Joseph Frank OldakowskiVP OF FINANCE AND CONTROLLER | 3,170 | $4.64 | $14,709 | 275,897 | −1.14% | 10b5-1 |
| Sep 15, 2026 SForm 4 → | Sep 16, 4:27 pm EDT | Conrad WaiCEO, Counterpart Health | 300,000 | $4.72 | $1,416,000 | 1,170,056 | −20.4% | 10b5-1 |
| Sep 15, 2026 SForm 4 → | Sep 15, 8:11 pm EDT | Karen SoaresChief Legal Officer | 6,846 | $4.78 | $32,724 | 1,607,371 | −0.42% | 10b5-1 |
| Sep 15, 2026 SForm 4 → | Sep 15, 7:48 pm EDT | Jamie L. ReynosoCEO, Medicare Advantage | 9,273 | $4.78 | $44,325 | 2,805,367 | −0.33% | 10b5-1 |
| Sep 14, 2026 SForm 4 → | Sep 14, 8:52 pm EDT | Joseph Frank OldakowskiVP OF FINANCE AND CONTROLLER | 20,000 | $5.16 | $103,200 | 279,067 | −6.69% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.